Synthesis of a Selective Orexin 1 Receptor Antagonist: Development of a Manufacturing Process─Part 4
In campaign 1, 97.75 kg of the orexin 1 receptor antagonist C4X3256 (1) was prepared in 3 stages from 2-methyl-5-(2H-1,2,3-triazol-2-yl)pyridine N-oxide (8). In the first stage, the nitrile group was introduced using trimethylsilyl cyanide and benzoyl chloride. In the second stage, the nitrile was hydrolyzed to the carboxylic acid using aqueous NaOH and the acid isolated by crystallization as the hemidiisopropylethylamine salt. In the third stage, 6-methyl-3-(2H-1,2,3-triazol-2-yl)pyridine-2-carboxylic acid (10) was coupled with the previously prepared amine (S)-2-(methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane hydrochloride salt (6) using T3P to produce C4X3256. In campaign 2, a combination of 1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride and 2-hydroxypyridine N-oxide was used in place of T3P as the coupling agent to produce 293.5 kg of C4X3256 (1).
Authors
- Jonathan C. Churchill (ORCID: https://orcid.org/0000-0003-4464-2702)
- Paul Leong
- James D. Firth (ORCID: https://orcid.org/0000-0003-2283-552X)
- John S Carey (ORCID: https://orcid.org/0000-0002-3654-0063)
- Andrew Knowles
Institutions
- The Priory Hospital (GB)
- Lonza (Switzerland) (CH)
Publication Details
- Journal
- Organic Process Research & Development
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1021/acs.oprd.6c00299
- Citations
- 3
- Primary Topic
- Chemical Synthesis and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 3.78